IMMUNRISE BIOCONTROL FRANCE’s Post

📣 Dutch delegation visiting Genopole to accelerate the development of alternative proteins 🌍 Developing a diet that contains less meat, is more respectful of the environment, and consumes less water and land, is a major challenge supported by Genopole in a collaborative dynamic with its European partners.  🥗 On April 17, the biocluster received a delegation from the Netherlands made up of around twenty companies and researchers from the alternative protein sector. #dietaryshift #proteintransition #alternativeproteins #sustainability #precisionfermentation https://lnkd.in/e2SD6PQ3

🌍 🦠 Reflecting on the Future of Microbiome, Food, and Health! 🍎 🌱 Yesterday, the Pharmabiotic Research Institute (PRI) had the privilege of participating in the insightful conference organized by INRAE, Université Paris-Saclay and Ferments du Futur: "Exploring the Shared Future of Microbiome, Food, and Health: How Can Microbiome R&I Leverage Food Systems Transition and Improve Human Health?" (https://lnkd.in/eFs3us6w) 📍 Where: Maison Irène et Frédéric Joliot-Curie, Brussels Céline Druart represented PRI as a panelist, sharing insights into microbiome regulatory science and its critical role in driving innovation at the intersection of food systems and health. The panel, chaired by Emmanuelle Maguin, also included the valuable expertise of Herve Affagard, MBA, Eng. and stefaan van der spiegel. This event brought together experts from various fields to discuss how microbiome research and innovation can contribute to a more sustainable and healthier future. We were thrilled to engage in these important conversations and to explore collaborative opportunities with fellow attendees. 💡 If you’re interested in learning more about PRI’s contributions or collaborating in the microbiome space, feel free to reach out! #MicrobiomeScience #RegulatoryScience #FoodSystems

🌍 🦠 Proud to Represent Pharmabiotic Research Institute (PRI) at This Key Event! 🍎 🌱 Yesterday, I had the privilege of representing the Pharmabiotic Research Institute (PRI) as a panelist at the insightful conference organized by INRAE, Université Paris-Saclay, and Ferments du Futur: "Exploring the Shared Future of Microbiome, Food, and Health: How Can Microbiome R&I Leverage Food Systems Transition and Improve Human Health?" (https://lnkd.in/eGBqRS6S) It was an honor to share PRI’s perspective on microbiome regulatory science and discuss its vital role in driving innovation at the intersection of food systems and health. The panel, chaired by Emmanuelle Maguin, was enriched by the expertise of Herve Affagard, MBA, Eng., and stefaan van der spiegel. Among other topics, we delved into the impact of new regulations on substances of human origin and their influence on microbiome research and innovation—a vital area for advancing the field. This event highlighted the importance of collaboration across disciplines to create sustainable and healthier food systems. I’m grateful for the opportunity to exchange ideas with such inspiring participants and look forward to seeing how these discussions shape the future of microbiome research. 💡 If you’d like to know more about PRI’s work or explore collaboration opportunities, feel free to connect! #MicrobiomeScience #RegulatoryScience #FoodSystems #Collaboration

🌎 As we move toward a better planet, interdisciplinary discussions are supporting progress in 🍎 #food #safety, #health, #sustainability and #innovation✅ 🍃 The #XLII #European #Culture #Collections’ #Organisation - #ECCO #conference is a key milestone in advancing our understanding of #biological systems and promoting sustainable #development through #microbial #resources preservation, characterization and exploitation. 🍃 🌐The event, organized by #CNR-#ISPA Consiglio Nazionale delle Ricerche, will be chaired by Antonio Moretti Giancarlo Perrone in #Bari from #18 to #20 #September 2024. It will foster a holistic approach to exploring the value of microbial resources and Microbial Biological Research Centers (#mBRCs). These are essential tools to: 🔬 Drive #transdisciplinary science in basic and applied research 💪 Foster resilience in the face of #climate #change and global challenges 🌱 Promote human, animal, and environmental health through the #OneHealth framework #ECCO  #OneHealth #Microbes #Microbiome #Sustainability #FoodSafety #Innovation

The creation of a UK microbiome biobank would be a wonderful resource for microbiome research 🧫🦠 In this thorough report, Craig Thomson discusses important IP considerations for this exciting and ambitious project! #MicrobiomeResearch #Microbiome #Biobank #IntellectualProperty #HGFEurope

Day 1 of Fungal Update: Mycology 2024 has begun! 😍 Whether you're joining us online or in London at the QEII Conference Centre, we're all set for an exciting day and can't wait to welcome you all and get started. 🚀 Remember to follow us and use our official hashtag #Mycology2024! #MedicalMycology #HealthcareConference #FungalUpdate #MycologyResearch

We are pleased to share our latest paper published in PLOS ONE. A UAM-UNAM collaboration from my postgraduate project where we describe the mosquito microbiome and their potential for biocontrol #mosquito #research #biocontrol #uam #unam

🌍🇫🇷 𝗙𝗿𝗮𝗻𝗰𝗲 𝗨𝗻𝘃𝗲𝗶𝗹𝘀 𝗔𝗺𝗯𝗶𝘁𝗶𝗼𝘂𝘀 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟰 𝗔𝗠𝗥 𝗥𝗼𝗮𝗱𝗺𝗮𝗽! 🇫🇷📜 In a major step forward, France has launched its new roadmap to combat antimicrobial resistance (AMR), setting bold objectives for the next decade. This interministerial strategy, outlined by the Ministry of Health, focuses on three key pillars: 1. Enhanced surveillance, 2. Promotion of innovation, and 3. Optimization of antimicrobial use across human, animal, and environmental sectors. At Inbeeo, we are closely following this groundbreaking strategy, and here are some top insights: 🔍 𝗢𝗻𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻: Strengthening collaboration across human, veterinary, and environmental health 💡 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗯𝗼𝗼𝘀𝘁: Increased funding for diagnostics and treatments to combat resistant infections ⚖️ 𝗧𝗶𝗴𝗵𝘁𝗲𝗿 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀: More stringent control on antimicrobial prescriptions and monitoring ⚙️ 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻: France is also exploring new financial regulation mechanisms, including a "Netflix-style" subscription model for antibiotics, to address the challenges of developing and ensuring the supply of health products. This experimental model, which could apply to antibiotics used in both human and animal health, will be developed with input from key stakeholders across the health and tech industries. 📊 The Inbeeo team are excited to see how these initiatives will reshape the AMR landscape and drive better global health outcomes! 🌟 Contributions by Tania Savant, Consultant at Inbeeo! ✨ Stay tuned! Inbeeo will be presenting our latest research on AMR at #ISPOR2024 in Barcelona 🇪🇸, where we’ll dive deeper into these trends and offer actionable. Please contact Enzo Straccia and Christel Jansen to hear more! #AMR #AntimicrobialResistance #HealthPolicy #MarketAccess #Inbeeo #ISPOR2024 #Innovation #Healthcare #OneHealth

🤔 yet another French paradox 🤔 France has the highest rate of antibiotic consumption across major markets but yet enjoys one of the lowest rates of antimicrobial resistance in the world With ~25 daily defined doses of antibiotics used per 1,000 inhabitants, we French people love to eat these miracle pills at the first signs of coughing. For 20 years, the French government even had to sponsor TV campaigns claiming that "les antibiotiques, c'est pas automatique". So what is the key to keeping resistance at bay? I see 2 success factors: 🧑✈️ antimicrobial stewardship - it is about which antibiotic you use as much as it is about how much you use. France kills all its targets set by the WHO for using antimicrobials that cause less resistance 🛣️ access pathways - because the race against AMR never ends, you need to bring new therapeutic options to kill superbugs, constantly. Innovative antibiotics enjoy preferential access pathways in France, in a similar fashion to orphan drugs This is why access policy is so important. It's great to see French authorities anticipating the challenges that the next decade will bring. Thank you Tania for a nice summary 👇🏼 https://lnkd.in/e9FJBueG

🐄 Can you imagine how much #animalhealth and #humanhealth are connected? Today, 60% of #infectiousdiseases are shared by humans and animals alike, and 75% of emerging infectious diseases originate in animals. 🔎 #PREZODE (Preventing Zoonotic Disease Emergence) is an innovative international initiative with the ambition to understand the risks of emergence of #zoonotic infectious diseases, to develop and implement innovative methods to improve prevention, early detection, and resilience in order to ensure rapid response to the risks of emerging infectious diseases of animal origin. Launched by France in January 2021, it has become global and gathers 235 members from 77 countries, including 25 governments and more than 200 research organizations, among which CSIRO and The University of Queensland. ⁉ Want to hear more about PREZODE and animal health science in France, New-Caledonia and Australia? Come on get your tickets for FAR into the Future of Health: https://lnkd.in/eeFVSF8G 📆 It's from the 26th to the 28th of March at University of Melbourne Meet with our amazing experts: Sam Hamilton - Acting Deputy CVO, Thomas Hüe - expert in biosecurity from New Caledonia, zeev noga - PREZODE Secretary General, Lee Skerratt - Leader of One Health Research Group at the University of Melbourne, Andy Sheppard ARCS PhD DIC FRES FTSE - Chief Research Scientist at CSIRO, Mark Blaskovich - Director of Translation, ARC Industrial Transformation Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance Vincent Hebrail RMIT University Monash University Department of Agriculture, Fisheries and Forestry Jennifer Davis Rachel Iglesias Francette Geraghty-Dusan Corissa Miller Jean-Luc ANGOT Jean-François HOCQUETTE Beth Cookson Emma Denehy The Embassy of France to Australia François-Ronan Dubois Nathalie Simenel-Amar Boris Toucas Kimberley Coulson Katherine Daniell